OR
IART icon

Olympiad Research’s Integra LifeSciences IART Stock Holding History

Olympiad Research’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,206
Closed -$299K – 289
2023
Q1 		$299K Buy
+5,206
New +$293K 0.35% 84
2020
Q1 		– Sell
-4,066
Closed -$237K – 311
2019
Q4 		$237K Buy
+4,066
New +$242K 0.18% 157

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Olympiad Research's IART Position: Q2 2023 in Review

Olympiad Research sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 5,206 shares — an estimated $299K sold.

Olympiad Research first reported a position in IART in Q4 2019 and held it in 2 quarters. The position peaked at $299K in Q1 2023. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

  • Olympiad Research reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
  • Olympiad Research sold 5,206 Integra LifeSciences shares in Q2 2023, an estimated $299K.
  • Olympiad Research first reported a position in Integra LifeSciences in Q4 2019 and held it in 2 quarters.
  • Olympiad Research's Integra LifeSciences position peaked at $299K in Q1 2023.
  • 283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Olympiad Research's 13F filing for Q2 2023, filed 25 Jul 2023.